Clinical Trial

Systemic Inflammatory Markers In Vocal Cord Lesions

Study acronym: SILVCL
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The aim of this study is to evaluate the levels of systemic inflammatory markers such as PIV, SII, and NPAR in patients with benign and premalignant laryngeal lesions and to determine the diagnostic accuracy of these values using ROC analysis.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-05-29.
Trial Details
NCT Number NCT07626125
Lead Sponsor Antalya Health Sciences University
Conditions Laryngeal Lesions, Systemic Inflammatory Process
Enrollment 250 participants
Start Date 2026-05-22
Primary Completion 2026-06-05 (estimated)
Study Completion 2026-06-19 (estimated)
Updated on ClinicalTrials.gov 2026-06-09